Quality Improvement (QI) Update
Recently we started a new initiative that involves working on ways to improve clinic flow and decrease the amount of waiting time. Currently average clinic visit is 90 minutes and 30 minutes are waiting. Our goal to decrease waiting time by half (15 minutes) which hopefully would decrease the total visit also.
We continue to try and improve transition to adulthood. We are almost finished with the first group and are now working on the second group. We are trying to refine the handoff from pediatric to adult providers. We are attempting to make it easier on all by doing a couple of things:
The transition team will review patients who are ready for transition at least 1 mo ahead of
We will put together a checklist for the transition team’s internal use to be sure that we notify providers and schedule all of the activities well ahead of time
We will ask for a volunteer pediatrics providers 2-4 weeks ahead of time
We will identify an adult provider who will be in that clinic visit
We will check in with the patient so that they can bring anyone that they wish to be present
We will be sure that all providers have access to the appropriate dot phrases for the handoff visit to simplify documentation-
Anxiety and depression screening is another project we are working on. The Cystic Fibrosis Foundation (CFF) has recommended we assess patients annually for anxiety and depression. We started with 25-35 year olds and will expand to those over 35. The next group will be the 18-24 year old patients. Adults will be screened first then the children. The long term plan is to screen all CF patients >12 years and pediatric family members for children under 18 years. We are trying to create a culture of normalcy about depression and anxiety. The members of the PFAB will be looking at education materials to post in the clinic.
We are working on several other projects including improving chest therapy when hospitalized. We also have been continuing to improve the number eligible patients who have their oral glucose tolerance test completed. We continue to show improvement in both of these areas.